ES8101855A1 - Un procedimiento para la preparacion de una composicion co- loidal lipidica de dihexanoil-lecitina - Google Patents

Un procedimiento para la preparacion de una composicion co- loidal lipidica de dihexanoil-lecitina

Info

Publication number
ES8101855A1
ES8101855A1 ES486157A ES486157A ES8101855A1 ES 8101855 A1 ES8101855 A1 ES 8101855A1 ES 486157 A ES486157 A ES 486157A ES 486157 A ES486157 A ES 486157A ES 8101855 A1 ES8101855 A1 ES 8101855A1
Authority
ES
Spain
Prior art keywords
dihexanoil
composition
procedure
preparation
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES486157A
Other languages
English (en)
Spanish (es)
Other versions
ES486157A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES486157A0 publication Critical patent/ES486157A0/es
Publication of ES8101855A1 publication Critical patent/ES8101855A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES486157A 1978-11-21 1979-11-20 Un procedimiento para la preparacion de una composicion co- loidal lipidica de dihexanoil-lecitina Expired ES8101855A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1192178 1978-11-21

Publications (2)

Publication Number Publication Date
ES486157A0 ES486157A0 (es) 1981-01-16
ES8101855A1 true ES8101855A1 (es) 1981-01-16

Family

ID=4378189

Family Applications (1)

Application Number Title Priority Date Filing Date
ES486157A Expired ES8101855A1 (es) 1978-11-21 1979-11-20 Un procedimiento para la preparacion de una composicion co- loidal lipidica de dihexanoil-lecitina

Country Status (22)

Country Link
US (1) US4271196A (enEXAMPLES)
EP (1) EP0011745B1 (enEXAMPLES)
JP (1) JPS5572111A (enEXAMPLES)
KR (1) KR850000584B1 (enEXAMPLES)
AR (1) AR225294A1 (enEXAMPLES)
AT (1) ATE501T1 (enEXAMPLES)
AU (1) AU529061B2 (enEXAMPLES)
CA (1) CA1136988A (enEXAMPLES)
DE (1) DE2961718D1 (enEXAMPLES)
DK (1) DK494079A (enEXAMPLES)
ES (1) ES8101855A1 (enEXAMPLES)
FI (1) FI793461A7 (enEXAMPLES)
GR (1) GR73668B (enEXAMPLES)
HU (1) HU180792B (enEXAMPLES)
IE (1) IE48659B1 (enEXAMPLES)
IL (1) IL58723A (enEXAMPLES)
MC (1) MC1297A1 (enEXAMPLES)
NO (1) NO793759L (enEXAMPLES)
NZ (1) NZ192118A (enEXAMPLES)
PH (1) PH15561A (enEXAMPLES)
PT (1) PT70478A (enEXAMPLES)
ZA (1) ZA796116B (enEXAMPLES)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2952115C2 (de) * 1979-12-22 1982-05-06 A. Nattermann & Cie GmbH, 5000 Köln Rosmarinsäure-Phospholipid-Komplex
US4374082A (en) * 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
US4457918A (en) * 1982-05-12 1984-07-03 The General Hospital Corporation Glycosides of vitamins A, E and K
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
US4721612A (en) * 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes
US4891208A (en) * 1985-04-10 1990-01-02 The Liposome Company, Inc. Steroidal liposomes
US5231112A (en) 1984-04-12 1993-07-27 The Liposome Company, Inc. Compositions containing tris salt of cholesterol hemisuccinate and antifungal
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US5023271A (en) * 1985-08-13 1991-06-11 California Biotechnology Inc. Pharmaceutical microemulsions
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
IT1269569B (it) * 1994-04-22 1997-04-08 Ugo Citernesi Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento
EP0682943B1 (de) * 1994-05-20 2003-08-20 GESELLSCHAFT FÜR MEDIZINISCHE FORSCHUNG UND WEITERBILDUNG e.V. GMF Lormetazepamhaltige Öl-in-Wasser-Emulsion
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
WO1997014407A1 (en) 1995-10-17 1997-04-24 Research Triangle Pharmaceuticals Insoluble drug delivery
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
EP1054678B1 (en) * 1998-02-11 2003-05-28 RTP Pharma Corporation Combination of steroid and polyunsaturated fatty acids for treatment of inflammatory conditions
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
WO1999061001A1 (en) 1998-05-29 1999-12-02 Rtp Pharma Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
KR100777647B1 (ko) 1998-08-19 2007-11-19 스키에파마 캐나다 인코포레이티드 프로포폴의 수용성 주사용 분산액
HK1042856B (zh) 1998-11-20 2007-07-27 Skyepharma Canada Inc. 可分散的磷脂稳定的微粒
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
CA2383233C (en) * 1999-09-21 2010-06-08 Rtp Pharma Inc. Surface modified particulate compositions of biologically active substances
AU5711501A (en) 2000-04-20 2001-11-07 Rtp Pharma Inc Improved water-insoluble drug particle process
CN100457090C (zh) 2000-08-31 2009-02-04 斯凯伊药品加拿大公司 磨制颗粒
US20020058065A1 (en) * 2000-09-20 2002-05-16 Pol-Henri Guivarc'h Insoluble drug particle compositions with improved fasted-fed effects
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
NZ527408A (en) * 2001-02-22 2005-04-29 Skyepharma Canada Inc Hydroxymethylglutarylcoenzyme A (HMG CoA) reductase inhibitor (or a statin) and a fibrate in a single effective oral dosage form to treat dyslipidaemia and dyslipoproteinaemia
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU29060A1 (enEXAMPLES) *
LU28584A1 (enEXAMPLES) *
FR2102537A5 (enEXAMPLES) * 1970-08-07 1972-04-07 Ugine Kuhlmann
FR2270887A1 (en) * 1974-05-16 1975-12-12 Chabrier De Lassauniere Pierre Prepn of lecithins and glycol-lecithins - by reaction of trimethylamine with 2-substd-2-oxo-1,3,2-dioxaphospholans
SE442014B (sv) * 1976-10-12 1985-11-25 Barry D Sears Syntetisk fosfatidyl-kvarter ammoniumforening till anvendning for solubilisering eller emulgering av vattenolosliga foreningar

Also Published As

Publication number Publication date
ES486157A0 (es) 1981-01-16
JPH0122243B2 (enEXAMPLES) 1989-04-25
MC1297A1 (fr) 1980-10-03
IE48659B1 (en) 1985-04-03
IL58723A0 (en) 1980-02-29
AU529061B2 (en) 1983-05-26
ATE501T1 (de) 1982-01-15
GR73668B (enEXAMPLES) 1984-03-28
JPS5572111A (en) 1980-05-30
AR225294A1 (es) 1982-03-15
US4271196A (en) 1981-06-02
EP0011745A1 (de) 1980-06-11
ZA796116B (en) 1980-11-26
PH15561A (en) 1983-02-11
IE792216L (en) 1980-05-21
CA1136988A (en) 1982-12-07
DE2961718D1 (en) 1982-02-18
EP0011745B1 (de) 1981-12-30
PT70478A (en) 1979-12-01
DK494079A (da) 1980-05-22
NO793759L (no) 1980-05-22
KR850000584B1 (ko) 1985-04-30
HU180792B (en) 1983-04-29
NZ192118A (en) 1981-12-15
FI793461A7 (fi) 1981-01-01
IL58723A (en) 1982-11-30
AU5282479A (en) 1980-05-29

Similar Documents

Publication Publication Date Title
ES8101855A1 (es) Un procedimiento para la preparacion de una composicion co- loidal lipidica de dihexanoil-lecitina
ATE64297T1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
AU537874B2 (en) Polyacrylate topical pharmaceutical
ES2060175T3 (es) Compuestos heterociclicos.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
CA2027592A1 (en) Solid pharmaceutical preparations of active form of vitamin d_ of improved stability
ES388980A1 (es) Procedimiento para la elaboracion de una lamina de unguentopara tratamientos dermatologicos.
ES446075A1 (es) Un procedimiento para la preparacion de unidades de dosifi- cacion oral con liberacion prolongada del componente terape-uticamente activo.
DE3775387D1 (de) Zusammensetzungen von katecholischen butanen mit zink.
DE2964963D1 (en) Medical food based on liver powder and process for its preparation
JPS5218813A (en) Plasters for the relief of cutaneous diseases
Eisenberger Supporting evidence for an active treatment program for advanced salivary gland carcinomas
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
Fischer et al. Severe contact dermatitis due to nitroglycerin patches
JPS5562013A (en) Aqueous poultice comprising transcutaneous absorbable anti-inflammatory agent
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
AU1417388A (en) Pharmaceutical preparation
DK430380A (da) Fremgangsmaade til fremstilling af piperidinderivater af 4,5-dialkyl-3-hydroxypyrrol-2-carboxylsyreestere
ATE35620T1 (de) Pharmazeutische zubereitung mit retardwirkung.
IT7921958A0 (it) Agente per attirare insetti composito, per i maschi della nottua del cavolo e procedimento per preparare i suoi principi attivi.
AU4831279A (en) New compounds
FR2336121A1 (fr) Nouveau procede de preparation de produits cosmetiques d'origine foetale, et produits obtenus
ATE66150T1 (de) Pharmazeutische zubereitung fuer orale verabreichung von eisensalzen, verwendbar zur behandlung von anaemien durch eisenmangel.
EP0389773A3 (de) Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO)
ES512748A0 (es) "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".